This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Express Scripts Challenges Tennessee Fair Rx Act: Another Attempt To Preserve The Status Quo

The legal challenge recently filed by Express Scripts against Tennessee’s Fair Rx Act is about far more than a single state law. At its core, the lawsuit is a fight over whether states have the authority to address...

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

FDA Issues New Guidance For Submitting Patent Information For Listing In The “Orange Book”

The FDA has released a draft guidance document clarifying the Orange Book patent listing submission process for new drug application holders and patent owners.

United States Healthcare

W

WilmerHale

CMS Proposes Permanent Framework For Medicare Drug Price Negotiation Program

On June 12, 2026, the Centers for Medicare and Medicaid Services (CMS) issued Proposed Rule CMS-4215-P, which would establish a permanent regulatory framework for the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA).

United States Healthcare

DM

Duane Morris LLP

FDA’s Focus Returns To Compounding And Telehealth: Another Wave Of Warning Letters

Just when the U.S. Food and Drug Administration (“FDA” or “agency”) enforcement activity seemed to slow in mid‑2026, the agency returned with a coordinated new wave.

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Character Flaw: Pennsylvania’s Crackdown On AI Playing Doctor

United States Healthcare

SR

McDermott Will & Schulte

The Rise Of Contingent Value: CVRs And Earnouts Reshape Life Sciences M&A

United States Healthcare

FH

Foley Hoag LLP

What United States v. Bankman-Fried Means For Health Care Fraud Defense

United States Healthcare

CM

Crowell & Moring LLP

What To Watch: Status Update On Peptide Regulation

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Health-e Law Episode 26, Part 2 | AI Adoption In Healthcare: Opportunities, Risks And The Future Of Care Delivery (Podcast)

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

FDA In Flux — June 2026 Newsletter

United States Healthcare

M

Mintz

Community & Commitment Report

United States Healthcare

M

Mintz

FDA In Flux - June 2026

United States Healthcare

M

Mintz

HHS-OIG Issues Unfavorable Advisory Opinion On Orthopedic Device Manufacturer's Proposed Royalty Payment Arrangement

United States Healthcare

BT

Barnes & Thornburg LLP

Smoke Is Not Fire: Fourth Circuit Rejects Stark And AKS Theories Built On Ordinary Business Practices And Conclusory Allegations

United States Healthcare

BB

Bass, Berry & Sims

See more

Webinars

See More

Recorded on 20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

Royalty Monetization In An Era Of Drug Pricing Pressure: How The IRA Is Affecting Royalty Monetizations

The Inflation Reduction Act, signed into law in August 2022, enacted significant changes in the way the government treats certain prescription drugs under the Medicare program.

United States Finance

GP

Goodwin Procter LLP

U.S. Supreme Court Weighs In On "Skinny Labels" And Inducement

The U.S. Supreme Court has issued a landmark ruling on pharmaceutical patent inducement, examining whether a generic manufacturer's "skinny label" strategy and marketing materials constitute active encouragement of infringing use.

United States IP

JD

Jones Day

FDA Issues New Guidance For Submitting Patent Information For Listing In The “Orange Book”

The FDA has released a draft guidance document clarifying the Orange Book patent listing submission process for new drug application holders and patent owners.

United States Healthcare

W

WilmerHale

CMS Proposes Permanent Framework For Medicare Drug Price Negotiation Program

United States Healthcare

DM

Duane Morris LLP

FDA’s Focus Returns To Compounding And Telehealth: Another Wave Of Warning Letters

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

New Jersey Cannabis Law: How The Sanders Decision Affects Employers

United States Employment

JL

Jackson Lewis P.C.

EPA Updates New Approach Methods To Replace Animal Testing For Chemical Assessments

United States Environment

BC

Bergeson & Campbell

FDA Just Added The First New Sunscreen Active Ingredient In Nearly 30 Years

United States International

DT

Diaz Trade Law

What To Watch: Status Update On Peptide Regulation

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

See more

Healthcare

Express Scripts Challenges Tennessee Fair Rx Act: Another Attempt To Preserve The Status Quo

The legal challenge recently filed by Express Scripts against Tennessee’s Fair Rx Act is about far more than a single state law. At its core, the lawsuit is a fight over whether states have the authority to address...

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

CMS Proposes Permanent Framework For Medicare Drug Price Negotiation Program

On June 12, 2026, the Centers for Medicare and Medicaid Services (CMS) issued Proposed Rule CMS-4215-P, which would establish a permanent regulatory framework for the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA).

United States Healthcare

DM

Duane Morris LLP

Character Flaw: Pennsylvania’s Crackdown On AI Playing Doctor

On May 1, 2026, the Pennsylvania Department of State, acting through its State Board of Medicine, filed a lawsuit against Character Technologies...

United States Healthcare

SR

McDermott Will & Schulte

The Rise Of Contingent Value: CVRs And Earnouts Reshape Life Sciences M&A

United States Healthcare

FH

Foley Hoag LLP

Republican Data Privacy Bills Could Impact Employers, Benefit Advisors

United States Privacy

HB

Hall Benefits Law

What United States v. Bankman-Fried Means For Health Care Fraud Defense

United States Healthcare

CM

Crowell & Moring LLP

Federal Circuit Reverses Judgment In Teva v. Eli Lilly, Upholding Validity Of Method Of Treatment Claims

United States IP

FH

Foley Hoag LLP

Health-e Law Episode 26, Part 2 | AI Adoption In Healthcare: Opportunities, Risks And The Future Of Care Delivery (Podcast)

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

The Price Isn’t Right: Emerging Patchwork Of State Surveillance Pricing Bans Creates Compliance Complications For Businesses

United States Anti-trust

SM

Sheppard, Mullin, Richter & Hampton LLP

See more

Life Sciences, Biotechnology & Nanotechnology

The Rise Of Contingent Value: CVRs And Earnouts Reshape Life Sciences M&A

CVR usage surged from 7 publicly disclosed deals in 2024 to 27 deals in 2025, with some CVRs representing over 70% of total deal value.

United States Healthcare

FH

Foley Hoag LLP

What To Watch: Status Update On Peptide Regulation

Peptides are the product du jour and most recently top of mind at the Food & Drug Administration (“FDA” or the “Agency”). Long relegated to the corners of biohacker and body building chatrooms, peptides...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Federal Circuit Reverses Judgment In Teva v. Eli Lilly, Upholding Validity Of Method Of Treatment Claims

The written description and enablement analyses are context-dependent; claim type may affect the written description and enablement analyses.

United States IP

FH

Foley Hoag LLP

The Price Isn’t Right: Emerging Patchwork Of State Surveillance Pricing Bans Creates Compliance Complications For Businesses

United States Anti-trust

SM

Sheppard, Mullin, Richter & Hampton LLP

FDA In Flux — June 2026 Newsletter

United States Healthcare

M

Mintz

Community & Commitment Report

United States Healthcare

M

Mintz

Alvotech’s BLA For Vedolizumab Biosimilar First To Be Accepted By FDA

United States Healthcare

GP

Goodwin Procter LLP

Incyte To Acquire Vega Therapeutics, Adding Phase 3 Bleeding Disorder Asset

United States Healthcare

GP

Goodwin Procter LLP

FDA Approves Lupin’s Ranibizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

See more

Latest Videos

See more

PBM Reform 2026: What Recent Legislation Means For The Industry (Video)

M

Mintz

In The Know: The Clean Beauty Trend Becomes State Law (Video)

LL

Loeb & Loeb LLP

GT Legal Food Talk Episode 30: Navigating Liquor Licensing: Inside The Legal Food & Beverage Landscape (Podcast)

GT

Greenberg Traurig, LLP

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Video)

W

WilmerHale

The Business Of Breakthroughs: Mayo Clinic On Innovation And The Future Of Care (Video)

AM

Alvarez & Marsal

Upcoming Events

AHLA Annual Meeting Cocktail Reception 2026

United States Healthcare

SR

McDermott Will & Schulte

DGE’s 7th Clinical Trial Agreements Summit

United States Healthcare

SR

McDermott Will & Schulte

AHLA Annual Meeting 2026

United States Healthcare

BB

Bass, Berry & Sims

2026 NCHCFA Fall Symposium

United States Healthcare

YM

Young Moore and Henderson

Goldmine Or Compliance Minefield? Navigating The Care Management Services Landscape

United States Healthcare

SR

McDermott Will & Schulte

Q3 Update On Federal And State Proposed Legislation Affecting Healthcare Consolidation

United States Healthcare

HK

Holland & Knight

AHLA’s Annual Meeting & In-House Counsel Program

United States Healthcare

FL

Foley & Lardner

AHLA Annual Meeting 2026

United States Healthcare

SR

McDermott Will & Schulte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More